跳至主要内容
临床试验/NCT01914211
NCT01914211撤回不适用

The Role of Tranexamic Acid in Reducing Blood Transfusion Requirements After Cardiopulmonary Bypass in Neonates

Aymen N Naguib1 个研究点 分布在 1 个国家开始时间: 2013年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
撤回
发起方
试验地点
1
主要终点
Level of postoperative hemostasis

研究概览

简要总结

This is an observational, prospective study to evaluate the role of tranexamic acid in reducing blood transfusion in neonates undergoing cardiopulmonary bypass.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
— 至 28 Days(Child)
性别
All
接受健康志愿者

入选标准

  • All neonates undergoing arterial switch or aortic arch procedure utilizing cardiopulmonary bypass (CPB).

排除标准

  • Jehovah's witness patients.

研究组 & 干预措施

Acute Normovolemic Hemodilution

Patients that receive acute normovolemic hemodilution prior to surgery.

干预措施: Acute Normovolemic Hemodilution (Procedure)

Tranexamic Acid

Patients that receive tranexamic acid during surgery.

干预措施: Tranexamic Acid (Drug)

结局指标

主要结局

Level of postoperative hemostasis

时间窗: 24 hours

Evaluating the body's ability to stop or decrease postoperative bleeding.

次要结局

  • Volume of blood transfusions(24 hours)

研究者

发起方
Aymen N Naguib
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Aymen N Naguib

Director of Pediatric Cardiothoracic Anesthesia

Nationwide Children's Hospital

研究点 (1)

Loading locations...

相似试验

The Role of Tranexamic Acid in Reducing Blood... | 临床试验